Related Experiment Video
Updated: Jul 10, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Thiophene containing triarylmethanes as antitubercular agents
Maloy Kumar Parai1, Gautam Panda, Vinita Chaturvedi
1Medicinal & Process Chemistry Division, Central Drug Research Institute, Lucknow 226001, UP, India.
Bioorganic & Medicinal Chemistry Letters
|November 13, 2007
Summary
Researchers synthesized novel thiophene-containing triarylmethane derivatives. These compounds demonstrated promising in vitro activity against Mycobacterium tuberculosis.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Microbiology
Background:
- Tuberculosis remains a significant global health challenge.
- Novel therapeutic agents are needed to combat Mycobacterium tuberculosis.
- Triarylmethane scaffolds are explored for antimicrobial properties.
Purpose of the Study:
- To synthesize and characterize novel thiophene-containing triarylmethane derivatives.
- To evaluate the in vitro antimycobacterial activity of these synthesized compounds.
Main Methods:
- Synthesis via Friedel-Crafts alkylation of diarylcarbinols.
- Incorporation of amino alkyl chains.
- In vitro susceptibility testing against Mycobacterium tuberculosis H37Rv.
Main Results:
- A series of thiophene-containing triarylmethane derivatives were successfully synthesized.
- The compounds exhibited antimycobacterial activity in the range of 3.12–12.5 µg/mL.
- Structure-activity relationships were investigated.
Conclusions:
- The synthesized thiophene-containing triarylmethane derivatives show potential as anti-tuberculosis agents.
- Further optimization and in vivo studies are warranted.
- This class of compounds represents a promising avenue for developing new tuberculosis treatments.
Related Concept Videos
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...